Enterprise League logo
MedAlliance Swiss Medical Technology Logo

MedAlliance Swiss Medical Technology

Nyon, Switzerland · Health and Medical

Do you work at MedAlliance Swiss Medical Technology?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#drug eluting balloons

#healthcare

#microreservoir technology

#cardiovascular

#endovascular

#sirolimus coated balloons

#coronary artery disease

#peripheral artery disease

#pta

#ptca

MedAlliance Swiss Medical Technology is a privately-owned medical technology company headquartered in Nyon, Switzerland, specializing in the development and commercialization of innovative drug-eluting balloon (DEB) technologies for the treatment of coronary and peripheral artery disease.Founded in 2008, MedAlliance has dedicated itself to pioneering solutions for patients suffering from life-threatening cardiovascular conditions.

Overview

MedAlliance Swiss Medical Technology is a privately-owned medical technology company headquartered in Nyon, Switzerland, specializing in the development and commercialization of innovative drug-eluting balloon (DEB) technologies for the treatment of coronary and peripheral artery disease.

Founded in 2008, MedAlliance has dedicated itself to pioneering solutions for patients suffering from life-threatening cardiovascular conditions. We leverage breakthrough proprietary technology, including our unique MicroReservoirs made from biodegradable polymer intermixed with the anti-restenotic drug sirolimus, to deliver sustained drug release and improve patient outcomes.

MedAlliance’s commitment to innovation is exemplified by its receipt of Breakthrough Device Designation Status from the US FDA for its SELUTION SLR coronary DEB, and subsequent CE Mark approvals for both coronary and peripheral indications. Our CAT technology further enhances these solutions, providing a secure and effective method for balloon delivery. We are a global company with operations spanning Europe, North America, and Asia, dedicated to advancing cardiovascular care.
Visit Official Website

Most teams do this before shortlisting


Contact Details

hola@knowledge.com.mx

Nyon, Switzerland, Rue de Rive 5

+4

Founded

2008

Company Type

Private Limited Company

Employees

50-100

Categories

Medical Technology Solutions
Manufacturing
Medical Equipment and Services

Keywords

#drug eluting balloons

#healthcare

#microreservoir technology

#cardiovascular

#endovascular

#sirolimus coated balloons

#coronary artery disease

#peripheral artery disease

#pta

#ptca

Awards

• 2026 OpenSee all

Services

Default Product Image
CAT Technology
Medical Equipment and Services

CAT (Cell Adherent Technology) is MedAlliance’s proprietary technology that enables the MicroReservoirs to be coated onto balloons and adhered to the vessel lumen during angioplasty. This ensures optimal drug delivery and sustained release, maximizing the effectiveness of SELUTION SLR.

N/A

Companies teams usually look at after MedAlliance Swiss Medical Technology

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.